Neuromodulation to Enhance Motor Function in HSP

Abroad (travel likely)Recruiting

Conditions

Hereditary Spastic Paraplegia

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

University of Kentucky, Lexington, Kentucky, United States
Contact: Study coordinator (Rahul Sachdeva, PhD) · rahulsachdeva@uky.edu · 8592574888
Contact: Study coordinator (Vivek K Pandey, PhD) · vivek.pandey@uky.edu · 8592574888

Study leads

Rahul Sachdeva, PhD
Principal Investigator
University of Kentucky

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Melpida: Recombinant Adeno-associated Virus (Serotype 9) Encoding a Codon Optimized Human AP4M1 Transgene (hAP4M1opt)

Spasticity, Muscle · Microcephaly · Intellectual Deficiency

Abroad (travel likely)RecruitingPHASE1, PHASE2

Dallas, United States

Phase 3 Efficacy Study With Concurrent Control of IT MELPIDA in SPG50.Concurrent Controls.

Hereditary Spastic Paraplegia Type 50

Abroad (travel likely)RecruitingPHASE3

Dallas, United States · Barcelona, Spain

STOP-HSP.Net: a Registry for Hereditary Spastic Paraplegia as an Integration Tool for Future Therapeutic Strategies

Hereditary Spastic Paraplegia

Abroad (travel likely)Recruiting

Pisa, Italy

Registry and Natural History Study for Early Onset Hereditary Spastic Paraplegia

Hereditary Spastic Paraplegia · SPG47 · SPG50

Abroad (travel likely)Recruiting

Boston, United States